The United Kingdom has become the first country in Europe to approve a new oral weight loss and diabetes medication, orforglipron, marketed as Foundayo. The Medicines and Healthcare products Regulatory Agency (MHRA) announced the authorization on Monday, August 10, 2026, for the once-daily tablet made by pharmaceutical...